Your browser doesn't support javascript.
loading
Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Play a Major Role in CD4+ T-Cell Impairment During Sepsis.
Gaborit, Benjamin J; Roquilly, Antoine; Louvet, Cédric; Sadek, Abderrahmane; Tessoulin, Benoit; Broquet, Alexis; Jacqueline, Cédric; Vourc'h, Mickael; Chaumette, Tanguy; Chauveau, Marie; Asquier, Antoine; Bourdiol, Alexandre; Le Mabecque, Virginie; Davieau, Marion; Caillon, Jocelyne; Boutoille, David; Coulpier, Fanny; Lemoine, Sophie; Ronin, Emilie; Poschmann, Jérémie; Salomon, Benoit L; Asehnoune, Karim.
Afiliación
  • Gaborit BJ; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Roquilly A; Department of Infectious Diseases, University Hospital of Nantes, CIC, INSERM, Nantes, France.
  • Louvet C; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Sadek A; Surgical Intensive Care Unit, Hotel Dieu, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Tessoulin B; Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
  • Broquet A; Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
  • Jacqueline C; Department of Biology, Faculty of Science, Moulay Ismail University, Meknes, Morocco.
  • Vourc'h M; Service d'Hématologie, INSERM U1232, Université de Nantes, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Chaumette T; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Chauveau M; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Asquier A; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Bourdiol A; Surgical Intensive Care Unit, Hotel Dieu, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Le Mabecque V; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Davieau M; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Caillon J; Department of Infectious Diseases, University Hospital of Nantes, CIC, INSERM, Nantes, France.
  • Boutoille D; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Coulpier F; Department of Infectious Diseases, University Hospital of Nantes, CIC, INSERM, Nantes, France.
  • Lemoine S; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Ronin E; Surgical Intensive Care Unit, Hotel Dieu, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Poschmann J; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Salomon BL; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
  • Asehnoune K; EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Université de Nantes, Nantes, France.
J Infect Dis ; 222(7): 1222-1234, 2020 09 01.
Article en En | MEDLINE | ID: mdl-32697326
Sepsis causes inflammation-induced immunosuppression with lymphopenia and alterations of CD4+ T-cell functions that renders the host prone to secondary infections. Whether and how regulatory T cells (Treg) are involved in this postseptic immunosuppression is unknown. We observed in vivo that early activation of Treg during Staphylococcus aureus sepsis induces CD4+ T-cell impairment and increases susceptibility to secondary pneumonia. The tumor necrosis factor receptor 2 positive (TNFR2pos) Treg subset endorsed the majority of effector immunosuppressive functions, and TNRF2 was particularly associated with activation of genes involved in cell cycle and replication in Treg, probably explaining their maintenance. Blocking or deleting TNFR2 during sepsis decreased the susceptibility to secondary infection. In humans, our data paralleled those in mice; the expression of CTLA-4 was dramatically increased in TNFR2pos Treg after culture in vitro with S. aureus. Our findings describe in vivo mechanisms underlying sepsis-induced immunosuppression and identify TNFR2pos Treg as targets for therapeutic intervention.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos CD4 / Linfocitos T Reguladores / Sepsis / Receptores Tipo II del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos CD4 / Linfocitos T Reguladores / Sepsis / Receptores Tipo II del Factor de Necrosis Tumoral Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Francia